Shen Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shen Li has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Hector L. Franco
Lineberger Comprehensive Cancer Center, Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
31 shared publications - Carla Rodriguez. Tirado
Department of Molecular Biology UT Southwestern Medical Center 75390 Dallas TX USA
30 shared publications - Christine A. Mills
Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
30 shared publications - Ingrid M. Montes-Rodriguez
Division of Clinical & Translational Cancer Research, Medical Sciences Campus University of Puerto Rico Comprehensive Cancer Center San Juan Puerto Rico
30 shared publications - Julie Dutil
Division of Clinical and Translational Cancer Research, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico
30 shared publications - Laura E. Herring
Michael Hooker Proteomics Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
30 shared publications
Latest Publications
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Supplementary Figure S4. FOXA1 domain diagram (top) plus plasmid map (bottom) for the FLAG-tagged N-terminal FOXA1-miniTurbo construct in a lentiviral plasmid.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Supplementary Figure S4. FOXA1 domain diagram (top) plus plasmid map (bottom) for the FLAG-tagged N-terminal FOXA1-miniTurbo construct in a lentiviral plasmid.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Full MEME-AME results corresponding to summary plotted in Fig. 3F (CSV file).
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Full MEME-AME results corresponding to summary plotted in Fig. 3F (CSV file).
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Supplementary Figure S5. FOXA1 domain diagram (top) plus plasmid map (bottom) for the HA-tagged C-terminal FOXA1-miniTurbo construct in a lentiviral plasmid.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Supplementary Figure S5. FOXA1 domain diagram (top) plus plasmid map (bottom) for the HA-tagged C-terminal FOXA1-miniTurbo construct in a lentiviral plasmid.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data File 2 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Full sequence for the HA-tagged C-terminal FOXA1-miniTurbo construct in a lentiviral plasmid (TXT file).
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data File 2 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Full sequence for the HA-tagged C-terminal FOXA1-miniTurbo construct in a lentiviral plasmid (TXT file).
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Data from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
FOXA1 is a pioneer transcription factor essential for chromatin accessibility and transcriptional regulation in hormone-driven cancers. In breast cancer, FOXA1 plays a central role in facilitating nuclear receptor binding, reprogramming enhancer landscapes, and promoting transcriptional changes associated with therapy resistance. Whereas FOXA1’s function has been primarily studied in the context of estrogen receptor-α (ER), its broader protein interaction network remains incompletely defined. In this study, we systematically map FOXA1-interacting proteins in ER-positive breast cancer cells using proximity-dependent biotin labeling (miniTurbo) combined with quantitative LC-MS/MS proteomics. We engineered MCF-7 cell lines stably expressing miniTurbo-tagged FOXA1 at either the N-terminus or C-terminus to ensure comprehensive coverage of interaction interfaces. This approach recovered known FOXA1 partners, including AR, MLL3, YAP1, and GATA3, and identified 157 previously unreported FOXA1 interactors. Notably, 42 of these novel partners, including NR2C2, were significantly associated with poor relapse-free survival in patients with ER-positive breast cancer. To demonstrate the utility of this resource, we characterized the FOXA1–NR2C2 interaction in depth. Integrating chromatin immunoprecipitation sequencing and RNA sequencing, we show that FOXA1 and NR2C2 co-occupy a subset of genomic regions and drive co-regulated transcriptional programs involved in tumor progression. Our study reveals an expanded FOXA1 interactome and new insights into its functional network in breast cancer, providing candidate proteins for further exploration as biomarkers or therapeutic targets.Implications:These findings expand the FOXA1 interactome in breast cancer and uncover new candidate proteins with potential as biomarkers and therapeutic targets in hormone-driven tumors.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
FOXA1 is a pioneer transcription factor essential for chromatin accessibility and transcriptional regulation in hormone-driven cancers. In breast cancer, FOXA1 plays a central role in facilitating nuclear receptor binding, reprogramming enhancer landscapes, and promoting transcriptional changes associated with therapy resistance. Whereas FOXA1’s function has been primarily studied in the context of estrogen receptor-α (ER), its broader protein interaction network remains incompletely defined. In this study, we systematically map FOXA1-interacting proteins in ER-positive breast cancer cells using proximity-dependent biotin labeling (miniTurbo) combined with quantitative LC-MS/MS proteomics. We engineered MCF-7 cell lines stably expressing miniTurbo-tagged FOXA1 at either the N-terminus or C-terminus to ensure comprehensive coverage of interaction interfaces. This approach recovered known FOXA1 partners, including AR, MLL3, YAP1, and GATA3, and identified 157 previously unreported FOXA1 interactors. Notably, 42 of these novel partners, including NR2C2, were significantly associated with poor relapse-free survival in patients with ER-positive breast cancer. To demonstrate the utility of this resource, we characterized the FOXA1–NR2C2 interaction in depth. Integrating chromatin immunoprecipitation sequencing and RNA sequencing, we show that FOXA1 and NR2C2 co-occupy a subset of genomic regions and drive co-regulated transcriptional programs involved in tumor progression. Our study reveals an expanded FOXA1 interactome and new insights into its functional network in breast cancer, providing candidate proteins for further exploration as biomarkers or therapeutic targets.Implications:These findings expand the FOXA1 interactome in breast cancer and uncover new candidate proteins with potential as biomarkers and therapeutic targets in hormone-driven tumors.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Supplementary Figure S4. FOXA1 domain diagram (top) plus plasmid map (bottom) for the FLAG-tagged N-terminal FOXA1-miniTurbo construct in a lentiviral plasmid.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Supplementary Figure S4. FOXA1 domain diagram (top) plus plasmid map (bottom) for the FLAG-tagged N-terminal FOXA1-miniTurbo construct in a lentiviral plasmid.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data File 1 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Full sequence for the FLAG-tagged N-terminal FOXA1-miniTurbo construct in a lentiviral plasmid (TXT file).
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data File 1 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Full sequence for the FLAG-tagged N-terminal FOXA1-miniTurbo construct in a lentiviral plasmid (TXT file).
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Full LC-MS/MS results (XLSX file)
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Full LC-MS/MS results (XLSX file)
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Supplementary Figure S6. Kaplan Meier plots describing the prognostic ability of NR2C2 expression across ER+ breast cancer patients segregated by molecular subtypes.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Mapping the FOXA1 Interactome in ER+ Breast Cancer Cells Using Proximity Labeling Reveals Novel Interactions with the Orphan Nuclear Receptor NR2C2
Supplementary Figure S6. Kaplan Meier plots describing the prognostic ability of NR2C2 expression across ER+ breast cancer patients segregated by molecular subtypes.